Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 192


Many multipotential gene-marked progenitor or stem cell clones contribute to hematopoiesis in nonhuman primates.

Kim HJ, Tisdale JF, Wu T, Takatoku M, Sellers SE, Zickler P, Metzger ME, Agricola BA, Malley JD, Kato I, Donahue RE, Brown KE, Dunbar CE.

Blood. 2000 Jul 1;96(1):1-8.


Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning.

Rosenzweig M, MacVittie TJ, Harper D, Hempel D, Glickman RL, Johnson RP, Farese AM, Whiting-Theobald N, Linton GF, Yamasaki G, Jordan CT, Malech HL.

Blood. 1999 Oct 1;94(7):2271-86.


Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability.

Tisdale JF, Hanazono Y, Sellers SE, Agricola BA, Metzger ME, Donahue RE, Dunbar CE.

Blood. 1998 Aug 15;92(4):1131-41.


In vitro T lymphopoiesis: a model system for stem cell gene therapy for AIDS.

Rosenzweig M, Marks DF, Hempel D, Johnson RP.

J Med Primatol. 1996 Jun;25(3):192-200.


The impact of low-dose busulfan on clonal dynamics in nonhuman primates.

Kuramoto K, Follman D, Hematti P, Sellers S, Laukkanen MO, Seggewiss R, Metzger ME, Krouse A, Donahue RE, von Kalle C, Dunbar CE.

Blood. 2004 Sep 1;104(5):1273-80. Epub 2004 May 4.


Developmental fate of hematopoietic stem cells: the study of individual hematopoietic clones at the level of antigen-responsive B lymphocytes.

Olovnikova NI, Drize NJ, Ershler MA, Nifontova IN, Belkina EV, Nikolaeva TN, Proskurina NV, Chertkov JL.

Hematol J. 2003;4(2):146-50.


Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation.

Dunbar CE, Cottler-Fox M, O'Shaughnessy JA, Doren S, Carter C, Berenson R, Brown S, Moen RC, Greenblatt J, Stewart FM, et al.

Blood. 1995 Jun 1;85(11):3048-57.


Prolonged high-level detection of retrovirally marked hematopoietic cells in nonhuman primates after transduction of CD34+ progenitors using clinically feasible methods.

Wu T, Kim HJ, Sellers SE, Meade KE, Agricola BA, Metzger ME, Kato I, Donahue RE, Dunbar CE, Tisdale JF.

Mol Ther. 2000 Mar;1(3):285-93.


Highly efficient gene transfer into preterm CD34 hematopoietic progenitor cells.

Shields LE, Kiem HP, Andrews RG.

Am J Obstet Gynecol. 2000 Sep;183(3):732-7.


Differential engraftment of genetically modified CD34(+) and CD34(-) hematopoietic cell subsets in lethally irradiated baboons.

Andrews RG, Peterson LJ, Morris J, Potter J, Heyward S, Gough M, Bryant E, Kiem HP.

Exp Hematol. 2000 May;28(5):508-18.


Persistent low-level engraftment of rhesus peripheral blood progenitor cells transduced with the fanconi anemia C gene after conditioning with low-dose irradiation.

Kang EM, Hanazano Y, Frare P, Vanin EF, De Witte M, Metzger M, Liu JM, Tisdale JF.

Mol Ther. 2001 Jun;3(6):911-9.


Retroviral transduction efficiency of G-CSF+SCF-mobilized peripheral blood CD34+ cells is superior to G-CSF or G-CSF+Flt3-L-mobilized cells in nonhuman primates.

Hematti P, Sellers SE, Agricola BA, Metzger ME, Donahue RE, Dunbar CE.

Blood. 2003 Mar 15;101(6):2199-205. Epub 2002 Nov 7.


Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia.

Kiem HP, Sellers S, Thomasson B, Morris JC, Tisdale JF, Horn PA, Hematti P, Adler R, Kuramoto K, Calmels B, Bonifacino A, Hu J, von Kalle C, Schmidt M, Sorrentino B, Nienhuis A, Blau CA, Andrews RG, Donahue RE, Dunbar CE.

Mol Ther. 2004 Mar;9(3):389-95.


Introduction of the green fluorescent protein gene into hematopoietic stem cells results in prolonged discrepancy of in vivo transduction levels between bone marrow progenitors and peripheral blood cells in nonhuman primates.

Hanazono Y, Terao K, Shibata H, Nagashima T, Ageyama N, Asano T, Ueda Y, Kato I, Kume A, Hasegawa M, Ozawa K.

J Gene Med. 2002 Sep-Oct;4(5):470-7.


Long-term in vivo expression of the human glucocerebrosidase gene in nonhuman primates after CD34+ hematopoietic cell transduction with cell-free retroviral vector preparations.

Xu LC, Karlsson S, Byrne ER, Kluepfel-Stahl S, Kessler SW, Agricola BA, Sellers S, Kirby M, Dunbar CE, Brady RO, et al.

Proc Natl Acad Sci U S A. 1995 May 9;92(10):4372-6.


Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and their lympho-myeloid progeny.

Cheng L, Du C, Lavau C, Chen S, Tong J, Chen BP, Scollay R, Hawley RG, Hill B.

Blood. 1998 Jul 1;92(1):83-92.


Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial.

Schmidt M, Hacein-Bey-Abina S, Wissler M, Carlier F, Lim A, Prinz C, Glimm H, Andre-Schmutz I, Hue C, Garrigue A, Le Deist F, Lagresle C, Fischer A, Cavazzana-Calvo M, von Kalle C.

Blood. 2005 Apr 1;105(7):2699-706. Epub 2004 Dec 7.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk